Skip to main content
University of Wisconsin–Madison
UW Crest
Wenthur Lab
  • Home
  • Members Expand Collapse
    • Lab Members
    • Collaborators
  • Research Expand Collapse
    • Our Research
    • Antidepressant Polypharmacologic
    • Psychedelic and Self-Identity (POIESIS)
    • Opioids and Immune Response
    • Synthetic Cannabinoid Detection / Treatment
    • Ghrelin Heterodimers and Reward
    • Psilocybin Experience and Outcomes (RECAP)
    • Neuroplastic and Psychoactive Agents
    • Addiction Vaccine Ethics
    • Naloxone Access Expansion
  • Publications
  • Gallery
  • News
  • Resources
  • Contact
  1. Home
  2. In the media
  3. Long-term opioid use in back-pain patients leads to production of anti-opioid antibodies

Long-term opioid use in back-pain patients leads to production of anti-opioid antibodies

Posted on August 19, 2020
Read the full article at: https://www.azolifesciences.com/news/20200819/Long-term-opioid-use-in-back-pain-patients-leads-to-production-of-anti-opioid-antibodies.aspx
Posted in In the media

Post navigation

Previous post: Patients taking opioids produce antibodies that may hinder anti-opioid vaccine
Next post: Negative side effects of opioids could be coming from users’ own immune systems

Site footer content

University logo that links to main university website Part of the Universities of Wisconsin

Website feedback, questions or accessibility issues: webmaster@pharmacy.wisc.edu | Learn more about accessibility at UW–Madison.

This site was built using the UW Theme | Privacy Notice | © 2025 Board of Regents of the University of Wisconsin System.